The store will not work correctly when cookies are disabled.
N'-(2-chlorobenzylidene)tetradecanehydrazide
ID: ALA1169784
PubChem CID: 46838952
Max Phase: Preclinical
Molecular Formula: C21H33ClN2O
Molecular Weight: 364.96
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Synonyms: N'-(2-Chlorobenzylidene)Tetradecanehydrazide | CHEMBL1169784|N'-(2-Chlorobenzylidene)Tetradecanehydrazide
Canonical SMILES: CCCCCCCCCCCCCC(=O)N/N=C/c1ccccc1Cl
Standard InChI: InChI=1S/C21H33ClN2O/c1-2-3-4-5-6-7-8-9-10-11-12-17-21(25)24-23-18-19-15-13-14-16-20(19)22/h13-16,18H,2-12,17H2,1H3,(H,24,25)/b23-18+
Standard InChI Key: IMISQSHQJLNSJS-PTGBLXJZSA-N
Molfile:
RDKit 2D
25 25 0 0 0 0 0 0 0 0999 V2000
15.6440 -21.8961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6428 -22.7241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3583 -23.1373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0752 -22.7236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0723 -21.8925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3565 -21.4830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3540 -20.6574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6377 -20.2467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6352 -19.4210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9190 -19.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9166 -18.1847 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2052 -19.4253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4896 -19.0147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7766 -19.4275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0635 -19.0189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3505 -19.4318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6374 -19.0230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9244 -19.4359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2113 -19.0272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4983 -19.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7852 -19.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0715 -19.4465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9289 -21.4834 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.3551 -19.0359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6415 -19.4511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 1 1 0
12 13 1 0
1 2 2 0
13 14 1 0
6 7 1 0
14 15 1 0
3 4 2 0
15 16 1 0
7 8 2 0
16 17 1 0
17 18 1 0
8 9 1 0
18 19 1 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 1 0
2 3 1 0
21 22 1 0
10 11 2 0
1 23 1 0
5 6 2 0
22 24 1 0
10 12 1 0
24 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.96 | Molecular Weight (Monoisotopic): 364.2281 | AlogP: 6.49 | #Rotatable Bonds: 14 |
Polar Surface Area: 41.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.85 | CX Basic pKa: 1.40 | CX LogP: 7.30 | CX LogD: 7.30 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.23 | Np Likeness Score: -1.14 |
References
1. Kumar D, Judge V, Narang R, Sangwan S, De Clercq E, Balzarini J, Narasimhan B.. (2010) Benzylidene/2-chlorobenzylidene hydrazides: synthesis, antimicrobial activity, QSAR studies and antiviral evaluation., 45 (7): [PMID:20347509] [10.1016/j.ejmech.2010.03.002] |